Study of Cerebellar Mutism Syndrome in Children With Brain Tumors in the Posterior Fossa Exploring Causes, Progress, and Treatment Approaches
Led by Rigshospitalet, Denmark · Updated on 2026-08-12
2000
Participants Needed
32
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research investigates why up to 25% of children who have surgery for tumors in the posterior fossa develop Cerebellar Mutism Syndrome CMS. CMS is a challenging condition marked by mutism, low muscle tone, coordination problems, and irritability. The study aims to understand the causes, clinical progress, and best ways to treat this syndrome in pediatric patients.
The study is an observational, prospective, multicenter project including at least 2000 children from Nordic countries who have posterior fossa central nervous system tumors and undergo surgery or biopsy. Patients are treated according to local standards, while clinical data and imaging are collected centrally. Blood samples are gathered for genetic analysis, and neurological and speech assessments are done before and repeatedly after surgery. Data are recorded at five key times before surgery, within 72 hours after surgery, 1-4 weeks post-surgery, around 2 months post-surgery, and approximately 12 months post-surgery. If patients have repeated surgeries within 12 months, follow-up restarts accordingly.
Participants will undergo neurological and speech function tests, including speech recordings, with extra assessments for children under 2 years. Blood samples are analyzed for genetic markers linked to CMS risk. Imaging and speech recordings are reviewed by specialists. Data quality is ensured by a third party. The main outcome measured is the development and progression of CMS one year after surgery. The study also tracks speech output reduction and treatments used during follow-up. Participation may last up to 12 months or longer if multiple surgeries occur.
CONDITIONS
Brief Title
Cerebellar Mutism Syndrome Study
Research Team
C
Caroline S K Schmidt, MD, PhD fellow
A
Astrid M Sehested, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Children younger than 18 years at the time of first tumor imaging
Tumor located in the cerebellum, 4th ventricle, or brainstem planned for surgical removal or open biopsy
Consent given by custodial parent(s)
You will not qualify if you...
None
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote as needed)
Data Collection and Monitoring
Duration - Up to 12 months post-surgery
Neurological and speech assessments are done before surgery and repeatedly after surgery. Blood samples for genetic analysis are collected. Imaging and clinical data are gathered and reviewed centrally.
Multiple visits for assessments at pre-op, within 72 hours, 1-4 weeks, 2 months, and 12 months post-op
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Tumour volume as a predictor of postoperative speech impairment in children undergoing resection of posterior fossa tumours: a prospective, multicentre study.
Aske Foldbjerg Laustsen, Shivaram Avula, Jonathan Grønbæk...
Preoperative hydrocephalus and the risk of postoperative speech impairment following posterior fossa tumour surgery in children: results from a prospective, multinational cohort study.
Aske Foldbjerg Laustsen, Radek Frič, Jonathan Kjær Grønbæk...
Postoperative speech impairment and cranial nerve deficits in children undergoing posterior fossa tumor surgery with intraoperative MRI - a prospective multinational study.
Aske Foldbjerg Laustsen, Jonathan Kjær Grønbæk, Radek Frič...